Arnaldo Lopez-Ruiz, MD
Critical Care Medicine · Orlando, FLNPI 1922376623
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (55.0%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Fresenius USA Marketing, Inc. accounts for 79.9% of it on its own, with 11 other manufacturers making up the rest. 2025 is the largest year on record at $4,665, more than ten times the $423 reported in 2019. Among critical care medicine clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 23 payments — averaging $252.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Fresenius USA Marketing, Inc.$5K
- La Jolla Pharmaceutical Company$272
- United Therapeutics Corporation$142
- Abiomed$133
- Edwards Lifesciences$130
- Genentech USA, Inc.$129
- plus $363 from 6 others
Across 4 payments — averaging $21,614 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Fresenius USA Marketing, Inc.$86K
What the payments were for
- Consulting fees$3,20055%
- Travel & lodging$1,01217%
- Food & beverage$1,55027%
- Education$521%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Fresenius USA Marketing, Inc. | 6 | $4,645 |
| La Jolla Pharmaceutical Company | 3 | $272 |
| United Therapeutics Corporation | 3 | $142 |
| Abiomed | 1 | $133 |
| Edwards Lifesciences | 2 | $130 |
| Genentech USA, Inc. | 1 | $129 |
| Bayer | 1 | $125 |
| Baxter Healthcare | 1 | $119 |
| Melinta Therapeutics, LLC | 1 | $49 |
| Merck | 2 | $47 |
| Mallinckrodt Hospital Products Inc. | 1 | $20 |
| Nuwellis, Inc. | 1 | $3 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,813 in reported general payments places this provider in the 90th percentile of 618 critical care medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other critical care medicine in Orlando
- Louis GuzziOrlando$635K
- Omid ZadOrlando$325K
- Charles HunleyOrlando$116K
- Martin ZamoraOrlando$44K
- Hammad BhattiOrlando$41K
- Dmitriy ZubkusOrlando$22K
- Amay ParikhOrlando$8K
- Sundeep GulianiOrlando$6K
- Fortune AlabiKissimmee$587K
- Debabrata BandyopadhyayTampa$398K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.